GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Days Sales Outstanding : 81.04 (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Days Sales Outstanding?

GlaxoSmithKline Consumer Nigeria's average Accounts Receivable for the three months ended in Jun. 2023 was ₦3,314 Mil. GlaxoSmithKline Consumer Nigeria's Revenue for the three months ended in Jun. 2023 was ₦3,732 Mil. Hence, GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding for the three months ended in Jun. 2023 was 81.04.

The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding or its related term are showing as below:

NSA:GLAXOSMITH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.46 Med: 67.58 Max: 111.46
Current: 108.59

During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest Days Sales Outstanding was 111.46. The lowest was 31.46. And the median was 67.58.

NSA:GLAXOSMITH's Days Sales Outstanding is not ranked
in the Drug Manufacturers industry.
Industry Median: 71.84 vs NSA:GLAXOSMITH: 108.59

GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding increased from Mar. 2022 (58.58) to Jun. 2023 (81.04).

GlaxoSmithKline Consumer Nigeria Days Sales Outstanding Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Days Sales Outstanding Chart

GlaxoSmithKline Consumer Nigeria Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

65.67

69.65

75.47

69.27

57.40

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial															58.58	67.39	84.45	74.70	81.04

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding falls into.

GlaxoSmithKline Consumer Nigeria Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (4351.443	+	3631.738)	/	2 )	/	25382.419	*	365
=	3991.5905					/	25382.419	*	365
=	57.40

GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (3631.738	+	2997.004)	/	2 )	/	3731.801	*	365 / 4
=	3314.371					/	3731.801	*	365 / 4
=	81.04

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

GlaxoSmithKline Consumer Nigeria Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines